Personalised medicine in asthma: from curative to preventive medicine

Laurent Guilleminault, Hakima Ouksel, Chantal Belleguic, Yannick Le Guen, Patrick Germaud, Emilie Desfleurs, Christophe Leroyer, Antoine Magnan

Source: Eur Respir Rev 2017; 26: 160010
Journal Issue: January
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Laurent Guilleminault, Hakima Ouksel, Chantal Belleguic, Yannick Le Guen, Patrick Germaud, Emilie Desfleurs, Christophe Leroyer, Antoine Magnan. Personalised medicine in asthma: from curative to preventive medicine. Eur Respir Rev 2017; 26: 160010

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Personalised medicine in asthma: time for action
Source: Eur Respir Rev, 26 (145) 170064; 10.1183/16000617.0064-2017
Year: 2017



Personalised targeted medicine
Source: Research Seminar 2015 - Personalising respiratory care in Europe
Year: 2015

What is evidence-based medicine?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006



Biomarkers and personalised medicine for asthma
Source: Eur Respir J, 53 (1) 1802094; 10.1183/13993003.02094-2018
Year: 2019



Personalised medicine in paediatric asthma, including from the patient's perspective
Source: International Congress 2016 – PG8 Paediatric asthma
Year: 2016


Excellency of anti-tuberculosis primary care: an evidence-based medicine challenge
Source: Eur Respir J 2005; 26: Suppl. 49, 142s
Year: 2005

The future of personalised medicine in COPD
Source: International Congress 2016 – Endotyping: the means to personalised medicine in lung disease
Year: 2016


Personalised medicine in exacerbations of COPD: the beginnings
Source: Eur Respir J 2012; 40: 1318-1319
Year: 2012


The impact of personalised therapies on respiratory medicine
Source: Eur Respir Rev 2013; 22: 72-74
Year: 2013



Evaluation of the use of e-learning in training management of asthma and COPD in general medicine.
Source: International Congress 2017 – Medical education, web and internet
Year: 2017

Personalised medicine: are we ready?
Source: Eur Respir Rev, 26 (145) 170088; 10.1183/16000617.0088-2017
Year: 2017



Breathe: palliative care in respiratory medicine
Source: Breathe, 13 (4) 267; 10.1183/20734735.017517
Year: 2017



Talk from Lisbon – Personalised medicine: an approach to holistic care
Source: ERS Satellites 2019
Year: 2019

In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

Palliative medicine services for those with chronic lung disease
Source: Annual Congress 2008 - Integrated care and long-term strategies
Year: 2008


Personalised medicine: how ready are we for this?
Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare
Year: 2013


The contribution of evidence-based medicine
Source: Annual Congress 2004 - PG17 - How to conduct a scientific survey on respiratory health
Year: 2004